(Q24647897)
Statements
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer (English)
0 references
20 October 2009
0 references
101
0 references
8
0 references
1233-40
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference